APO Research
Talk to an analyst

APO RESEARCH · REPORT

Kidney Cancer Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Kidney Cancer Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025194 pages

Choose your research edition.

Industry ResearchKidney Cancer Treatment Drugs Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Kidney Cancer Treatment Drugs Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Kidney Cancer Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Kidney Cancer Treatment Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Kidney Cancer Treatment Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Kidney Cancer Treatment Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Kidney Cancer Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Kidney Cancer Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Kidney Cancer Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Kidney Cancer Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Kidney Cancer Treatment Drugs include Eisai, Novartis, Merck, Roche, Pfizer, Bayer, AstraZeneca, Prometheus Labs and Incyte, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Kidney Cancer Treatment Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Kidney Cancer Treatment Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Kidney Cancer Treatment Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Kidney Cancer Treatment Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Kidney Cancer Treatment Drugs Segment by Company

Eisai

Novartis

Merck

Roche

Pfizer

Bayer

AstraZeneca

Prometheus Labs

Incyte

Exelixis

Bristol-Myers Squibb

Aveo Pharmaceuticals

Argos Therapeutics

Amgen/Allergan

Kidney Cancer Treatment Drugs Segment by Type

Angiogenesis Inhibitors

Cytokine Immunotherapy (IL-2)

Monoclonal Antibodies

mTOR Inhibitors

Kidney Cancer Treatment Drugs Segment by Application

Research Institutes

Hospitals

Diagnostic Centers

Others

Kidney Cancer Treatment Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kidney Cancer Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Kidney Cancer Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kidney Cancer Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Kidney Cancer Treatment Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Kidney Cancer Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Kidney Cancer Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Kidney Cancer Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Kidney Cancer Treatment Drugs Industry Trends Table 2. Kidney Cancer Treatment Drugs Industry Drivers Table 3. Kidney Cancer Treatment Drugs Industry Opportunities and Challenges Table 4. Kidney Cancer Treatment Drugs Industry Restraints Table 5. Global Kidney Cancer Treatment Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Kidney Cancer Treatment Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Kidney Cancer Treatment Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Kidney Cancer Treatment Drugs Sales Market Share by Manufacturers Table 9. Global Kidney Cancer Treatment Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Kidney Cancer Treatment Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Kidney Cancer Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Kidney Cancer Treatment Drugs Manufacturers, Product Type & Application Table 13. Global Kidney Cancer Treatment Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Kidney Cancer Treatment Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Angiogenesis Inhibitors Table 17. Major Manufacturers of Cytokine Immunotherapy (IL-2) Table 18. Major Manufacturers of Monoclonal Antibodies Table 19. Major Manufacturers of mTOR Inhibitors Table 20. Global Kidney Cancer Treatment Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Kidney Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 22. Global Kidney Cancer Treatment Drugs Sales by Type (2027-2032) & (K Units) Table 23. Global Kidney Cancer Treatment Drugs Sales Market Share by Type (2021-2026) Table 24. Global Kidney Cancer Treatment Drugs Sales Market Share by Type (2027-2032) Table 25. Global Kidney Cancer Treatment Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Kidney Cancer Treatment Drugs Revenue by Type (2021-2026) & (K Units) Table 27. Global Kidney Cancer Treatment Drugs Revenue by Type (2027-2032) & (K Units) Table 28. Global Kidney Cancer Treatment Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Kidney Cancer Treatment Drugs Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Research Institutes Table 31. Major Manufacturers of Hospitals Table 32. Major Manufacturers of Diagnostic Centers Table 33. Major Manufacturers of Others Table 34. Global Kidney Cancer Treatment Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Kidney Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 36. Global Kidney Cancer Treatment Drugs Sales by Application (2027-2032) & (K Units) Table 37. Global Kidney Cancer Treatment Drugs Sales Market Share by Application (2021-2026) Table 38. Global Kidney Cancer Treatment Drugs Sales Market Share by Application (2027-2032) Table 39. Global Kidney Cancer Treatment Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Kidney Cancer Treatment Drugs Revenue by Application (2021-2026) & (K Units) Table 41. Global Kidney Cancer Treatment Drugs Revenue by Application (2027-2032) & (K Units) Table 42. Global Kidney Cancer Treatment Drugs Revenue Market Share by Application (2021-2026) Table 43. Global Kidney Cancer Treatment Drugs Revenue Market Share by Application (2027-2032) Table 44. Global Kidney Cancer Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Kidney Cancer Treatment Drugs Sales by Region (2021-2026) & (K Units) Table 46. Global Kidney Cancer Treatment Drugs Sales Market Share by Region (2021-2026) Table 47. Global Kidney Cancer Treatment Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Kidney Cancer Treatment Drugs Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Kidney Cancer Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Kidney Cancer Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 51. North America Kidney Cancer Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 52. Europe Kidney Cancer Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Kidney Cancer Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 54. Europe Kidney Cancer Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Kidney Cancer Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Kidney Cancer Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Kidney Cancer Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Kidney Cancer Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Kidney Cancer Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Kidney Cancer Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 61. Global Kidney Cancer Treatment Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Kidney Cancer Treatment Drugs Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Kidney Cancer Treatment Drugs Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Kidney Cancer Treatment Drugs Revenue Market Share by Region (2021-2026) Table 65. Global Kidney Cancer Treatment Drugs Revenue Market Share by Region (2027-2032) Table 66. Eisai Company Information Table 67. Eisai Business Overview Table 68. Eisai Kidney Cancer Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Eisai Kidney Cancer Treatment Drugs Product Portfolio Table 70. Eisai Recent Development Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Kidney Cancer Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Novartis Kidney Cancer Treatment Drugs Product Portfolio Table 75. Novartis Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Kidney Cancer Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Merck Kidney Cancer Treatment Drugs Product Portfolio Table 80. Merck Recent Development Table 81. Roche Company Information Table 82. Roche Business Overview Table 83. Roche Kidney Cancer Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Roche Kidney Cancer Treatment Drugs Product Portfolio Table 85. Roche Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Kidney Cancer Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Pfizer Kidney Cancer Treatment Drugs Product Portfolio Table 90. Pfizer Recent Development Table 91. Bayer Company Information Table 92. Bayer Business Overview Table 93. Bayer Kidney Cancer Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Bayer Kidney Cancer Treatment Drugs Product Portfolio Table 95. Bayer Recent Development Table 96. AstraZeneca Company Information Table 97. AstraZeneca Business Overview Table 98. AstraZeneca Kidney Cancer Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. AstraZeneca Kidney Cancer Treatment Drugs Product Portfolio Table 100. AstraZeneca Recent Development Table 101. Prometheus Labs Company Information Table 102. Prometheus Labs Business Overview Table 103. Prometheus Labs Kidney Cancer Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Prometheus Labs Kidney Cancer Treatment Drugs Product Portfolio Table 105. Prometheus Labs Recent Development Table 106. Incyte Company Information Table 107. Incyte Business Overview Table 108. Incyte Kidney Cancer Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Incyte Kidney Cancer Treatment Drugs Product Portfolio Table 110. Incyte Recent Development Table 111. Exelixis Company Information Table 112. Exelixis Business Overview Table 113. Exelixis Kidney Cancer Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Exelixis Kidney Cancer Treatment Drugs Product Portfolio Table 115. Exelixis Recent Development Table 116. Bristol-Myers Squibb Company Information Table 117. Bristol-Myers Squibb Business Overview Table 118. Bristol-Myers Squibb Kidney Cancer Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Bristol-Myers Squibb Kidney Cancer Treatment Drugs Product Portfolio Table 120. Bristol-Myers Squibb Recent Development Table 121. Aveo Pharmaceuticals Company Information Table 122. Aveo Pharmaceuticals Business Overview Table 123. Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Product Portfolio Table 125. Aveo Pharmaceuticals Recent Development Table 126. Argos Therapeutics Company Information Table 127. Argos Therapeutics Business Overview Table 128. Argos Therapeutics Kidney Cancer Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Argos Therapeutics Kidney Cancer Treatment Drugs Product Portfolio Table 130. Argos Therapeutics Recent Development Table 131. Amgen/Allergan Company Information Table 132. Amgen/Allergan Business Overview Table 133. Amgen/Allergan Kidney Cancer Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Amgen/Allergan Kidney Cancer Treatment Drugs Product Portfolio Table 135. Amgen/Allergan Recent Development Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Kidney Cancer Treatment Drugs Distributors List Table 139. Kidney Cancer Treatment Drugs Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Kidney Cancer Treatment Drugs Product Image Figure 2. Global Kidney Cancer Treatment Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Kidney Cancer Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Kidney Cancer Treatment Drugs Sales (2021-2032) & (K Units) Figure 5. Global Kidney Cancer Treatment Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Kidney Cancer Treatment Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Angiogenesis Inhibitors Image Figure 9. Cytokine Immunotherapy (IL-2) Image Figure 10. Monoclonal Antibodies Image Figure 11. mTOR Inhibitors Image Figure 12. Global Kidney Cancer Treatment Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Kidney Cancer Treatment Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Kidney Cancer Treatment Drugs Sales Market Share by Type (2021-2032) Figure 15. Global Kidney Cancer Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Kidney Cancer Treatment Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Kidney Cancer Treatment Drugs Revenue Market Share by Type (2021-2032) Figure 18. Research Institutes Image Figure 19. Hospitals Image Figure 20. Diagnostic Centers Image Figure 21. Others Image Figure 22. Global Kidney Cancer Treatment Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Kidney Cancer Treatment Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Kidney Cancer Treatment Drugs Sales Market Share by Application (2021-2032) Figure 25. Global Kidney Cancer Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Kidney Cancer Treatment Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Kidney Cancer Treatment Drugs Revenue Market Share by Application (2021-2032) Figure 28. North America Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Kidney Cancer Treatment Drugs Sales Market Share by Country (2021-2032) Figure 30. U.S. Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Kidney Cancer Treatment Drugs Sales Market Share by Country (2021-2032) Figure 35. Germany Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Kidney Cancer Treatment Drugs Sales Market Share by Country (2021-2032) Figure 42. China Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Kidney Cancer Treatment Drugs Sales Market Share by Country (2021-2032) Figure 50. Brazil Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Kidney Cancer Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Kidney Cancer Treatment Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Kidney Cancer Treatment Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 61. North America Kidney Cancer Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Europe Kidney Cancer Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Kidney Cancer Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Kidney Cancer Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Kidney Cancer Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Kidney Cancer Treatment Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Kidney Cancer Treatment Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Angiogenesis Inhibitors
  • Cytokine Immunotherapy (IL-2)
  • Monoclonal Antibodies
  • mTOR Inhibitors
Applications
  • Research Institutes
  • Hospitals
  • Diagnostic Centers
  • Others
Companies covered
  • Eisai
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • Bayer
  • AstraZeneca
  • Prometheus Labs
  • Incyte
  • Exelixis
  • Bristol-Myers Squibb
  • Aveo Pharmaceuticals
  • Argos Therapeutics
  • Amgen/Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Kidney Cancer Treatment Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Kidney Cancer Treatment Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Kidney Cancer Treatment Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Kidney Cancer Treatment Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Kidney Cancer Treatment Drugs Market Dynamics
  1. 2.1 Kidney Cancer Treatment Drugs Industry Trends
  2. 2.2 Kidney Cancer Treatment Drugs Industry Drivers
  3. 2.3 Kidney Cancer Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Kidney Cancer Treatment Drugs Industry Restraints
3 Kidney Cancer Treatment Drugs Market by Manufacturers
  1. 3.1 Global Kidney Cancer Treatment Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Kidney Cancer Treatment Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Kidney Cancer Treatment Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Kidney Cancer Treatment Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Kidney Cancer Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Kidney Cancer Treatment Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Kidney Cancer Treatment Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Kidney Cancer Treatment Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Kidney Cancer Treatment Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Kidney Cancer Treatment Drugs Tier 1, Tier 2, and Tier 3
4 Kidney Cancer Treatment Drugs Market by Type
  1. 4.1 Kidney Cancer Treatment Drugs Type Introduction
  2. 4.1.1 Angiogenesis Inhibitors
  3. 4.1.2 Cytokine Immunotherapy (IL-2)
  4. 4.1.3 Monoclonal Antibodies
  5. 4.1.4 mTOR Inhibitors
  6. 4.2 Global Kidney Cancer Treatment Drugs Sales by Type
  7. 4.2.1 Global Kidney Cancer Treatment Drugs Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Kidney Cancer Treatment Drugs Sales by Type (2021-2032)
  9. 4.2.3 Global Kidney Cancer Treatment Drugs Sales Market Share by Type (2021-2032)
  10. 4.3 Global Kidney Cancer Treatment Drugs Revenue by Type
  11. 4.3.1 Global Kidney Cancer Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Kidney Cancer Treatment Drugs Revenue by Type (2021-2032)
  13. 4.3.3 Global Kidney Cancer Treatment Drugs Revenue Market Share by Type (2021-2032)
5 Kidney Cancer Treatment Drugs Market by Application
  1. 5.1 Kidney Cancer Treatment Drugs Application Introduction
  2. 5.1.1 Research Institutes
  3. 5.1.2 Hospitals
  4. 5.1.3 Diagnostic Centers
  5. 5.1.4 Others
  6. 5.2 Global Kidney Cancer Treatment Drugs Sales by Application
  7. 5.2.1 Global Kidney Cancer Treatment Drugs Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Kidney Cancer Treatment Drugs Sales by Application (2021-2032)
  9. 5.2.3 Global Kidney Cancer Treatment Drugs Sales Market Share by Application (2021-2032)
  10. 5.3 Global Kidney Cancer Treatment Drugs Revenue by Application
  11. 5.3.1 Global Kidney Cancer Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Kidney Cancer Treatment Drugs Revenue by Application (2021-2032)
  13. 5.3.3 Global Kidney Cancer Treatment Drugs Revenue Market Share by Application (2021-2032)
6 Global Kidney Cancer Treatment Drugs Sales by Region
  1. 6.1 Global Kidney Cancer Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Kidney Cancer Treatment Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Kidney Cancer Treatment Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Kidney Cancer Treatment Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Kidney Cancer Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Kidney Cancer Treatment Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Kidney Cancer Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Kidney Cancer Treatment Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Kidney Cancer Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Kidney Cancer Treatment Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Kidney Cancer Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Kidney Cancer Treatment Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Kidney Cancer Treatment Drugs Revenue by Region
  1. 7.1 Global Kidney Cancer Treatment Drugs Revenue by Region
  2. 7.1.1 Global Kidney Cancer Treatment Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Kidney Cancer Treatment Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Kidney Cancer Treatment Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Kidney Cancer Treatment Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Kidney Cancer Treatment Drugs Revenue (2021-2032)
  8. 7.2.2 North America Kidney Cancer Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Kidney Cancer Treatment Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Kidney Cancer Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Kidney Cancer Treatment Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Kidney Cancer Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Kidney Cancer Treatment Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Kidney Cancer Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai
  2. 8.1.1 Eisai Company Information
  3. 8.1.2 Eisai Business Overview
  4. 8.1.3 Eisai Kidney Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Kidney Cancer Treatment Drugs Product Portfolio
  6. 8.1.5 Eisai Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Kidney Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Kidney Cancer Treatment Drugs Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Kidney Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Kidney Cancer Treatment Drugs Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Kidney Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche Kidney Cancer Treatment Drugs Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Kidney Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Kidney Cancer Treatment Drugs Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Bayer
  32. 8.6.1 Bayer Company Information
  33. 8.6.2 Bayer Business Overview
  34. 8.6.3 Bayer Kidney Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Kidney Cancer Treatment Drugs Product Portfolio
  36. 8.6.5 Bayer Recent Developments
  37. 8.7 AstraZeneca
  38. 8.7.1 AstraZeneca Company Information
  39. 8.7.2 AstraZeneca Business Overview
  40. 8.7.3 AstraZeneca Kidney Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AstraZeneca Kidney Cancer Treatment Drugs Product Portfolio
  42. 8.7.5 AstraZeneca Recent Developments
  43. 8.8 Prometheus Labs
  44. 8.8.1 Prometheus Labs Company Information
  45. 8.8.2 Prometheus Labs Business Overview
  46. 8.8.3 Prometheus Labs Kidney Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Prometheus Labs Kidney Cancer Treatment Drugs Product Portfolio
  48. 8.8.5 Prometheus Labs Recent Developments
  49. 8.9 Incyte
  50. 8.9.1 Incyte Company Information
  51. 8.9.2 Incyte Business Overview
  52. 8.9.3 Incyte Kidney Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Incyte Kidney Cancer Treatment Drugs Product Portfolio
  54. 8.9.5 Incyte Recent Developments
  55. 8.10 Exelixis
  56. 8.10.1 Exelixis Company Information
  57. 8.10.2 Exelixis Business Overview
  58. 8.10.3 Exelixis Kidney Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Exelixis Kidney Cancer Treatment Drugs Product Portfolio
  60. 8.10.5 Exelixis Recent Developments
  61. 8.11 Bristol-Myers Squibb
  62. 8.11.1 Bristol-Myers Squibb Company Information
  63. 8.11.2 Bristol-Myers Squibb Business Overview
  64. 8.11.3 Bristol-Myers Squibb Kidney Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bristol-Myers Squibb Kidney Cancer Treatment Drugs Product Portfolio
  66. 8.11.5 Bristol-Myers Squibb Recent Developments
  67. 8.12 Aveo Pharmaceuticals
  68. 8.12.1 Aveo Pharmaceuticals Company Information
  69. 8.12.2 Aveo Pharmaceuticals Business Overview
  70. 8.12.3 Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Product Portfolio
  72. 8.12.5 Aveo Pharmaceuticals Recent Developments
  73. 8.13 Argos Therapeutics
  74. 8.13.1 Argos Therapeutics Company Information
  75. 8.13.2 Argos Therapeutics Business Overview
  76. 8.13.3 Argos Therapeutics Kidney Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Argos Therapeutics Kidney Cancer Treatment Drugs Product Portfolio
  78. 8.13.5 Argos Therapeutics Recent Developments
  79. 8.14 Amgen/Allergan
  80. 8.14.1 Amgen/Allergan Company Information
  81. 8.14.2 Amgen/Allergan Business Overview
  82. 8.14.3 Amgen/Allergan Kidney Cancer Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Amgen/Allergan Kidney Cancer Treatment Drugs Product Portfolio
  84. 8.14.5 Amgen/Allergan Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Kidney Cancer Treatment Drugs Value Chain Analysis
  2. 9.1.1 Kidney Cancer Treatment Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Kidney Cancer Treatment Drugs Production Mode & Process
  6. 9.2 Kidney Cancer Treatment Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Kidney Cancer Treatment Drugs Distributors
  9. 9.2.3 Kidney Cancer Treatment Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst